CoChat

MMP‐2, ‐3 and ‐9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease

Baig, S., Kehoe, P. G., Love, S. · 2008 · Neuropathology and Applied Neurobiology
Cited by 38

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Matrix metalloproteinases (MMPs) ‐2, ‐3 and ‐9 are up‐regulated in several cell types on exposure to amyloid β peptide (Aβ) and have Aβ‐degrading activity in vitro. The aims of this study were to determine (i) the distribution of MMP‐2, ‐3 and ‐9 in the cerebral cortex in Alzheimer's disease (AD) and control brains; (ii) whether the levels and activity of these proteases are increased in AD; and (iii) whether their activity is related to Aβ load. In addition, we examined whether promoter polymorphisms in the MMP‐3 and ‐9 genes are associated with AD in the study cohort. Paraffin sections of frontal lobe from AD and control cases were immunostained for MMP‐2, ‐3 and ‐9 and tissue homogenates used for MMP activity assays. DNA from these cases was genotyped for the MMP‐3 5A/6A (‐1171) and MMP‐9 C‐1562T promoter polymorphisms. Immunohistochemistry revealed MMP‐3 in plaques and both MMP‐3 and ‐9 around scattered neurones. The levels and activity of all three MMPs were similar in AD and control brains and bore no relationship to Aβ load. Analysis of MMP‐3 ‐1171 5A/6A allele frequencies showed that the 6A allele (with reduced promoter activity) was associated with AD; the MMP‐9 C‐1562T polymorphism was not. The levels and activities of MMP‐2, ‐3 and ‐9 are not increased in the frontal cortex in AD and are not related to Aβ load. Our findings suggest that altered expression of these proteases does not make a significant contribution to the accumulation of Aβ in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2990.2007.00897.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 38

Metadata

Authors
Baig, S., Kehoe, P. G., & Love, S.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2007-10-31
Volume
34
Issue
2
Pages
205-215
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2060693209
Cited by
38
References
5
FWCI
1.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MMP‐2, ‐3 and ‐9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease. https://app.cochat.ai/papers/10.1111/j.1365-2990.2007.00897.x
The paper
Baig, S., Kehoe, P. G., & Love, S. (2008). MMP‐2, ‐3 and ‐9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.2007.00897.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.